TOPGUN-PilotNCT06718439
Hemoglobin Levels for Blood Transfusions During and After Surgery
StatusActive, Not Recruiting
PhaseNot applicable
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 13 words
- Enrollment closed, study ongoing
- Primary completion date changed from estimate of Apr 15, 2026 to Sep 16, 2026
- Site details revised
- Notable Trial status: Not Yet Recruiting to Recruiting
- Primary completion date: Jan 15, 2026 to Apr 15, 2026
- Site details revised
- Notable Start date: Jan 15, 2025 to Apr 16, 2025v2
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Recruitment rate
Timeframe: 12 months post site initiation
Intervention adherence
Timeframe: From enrollment up to 6 hours in the Post-Anesthetic Care Unit
Participant retention
Timeframe: From randomization to 30 days post surgery.
Arms and interventions
Restrictive transfusion strategyExperimental
The restrictive transfusion strategy will consist of administering red blood cell transfusion when the participant's hemoglobin level is measured below 70 g/L or to maintain a hemoglobin target range of 70-80 g/L.
Liberal transfusion strategyExperimental
The liberal transfusion strategy will consist of administering red blood cell transfusion when the participant's hemoglobin level is measured below 90 g/L or to maintain a hemoglobin target range of 90-100 g/L.
Procedures: Restrictive Transfusion, Liberal transfusion
Sites
1 site in 1 country
- The Ottawa HospitalOttawa, Ontario, Canada